Sunrise Oncology Centre Introduces Comprehensive Cancer Care in Vasai, a First for Palghar District
Sunrise Oncology Centre, a leading provider of comprehensive cancer care, is proud to announce the opening of its new facility in Vasai, marking the establishment of the first cancer registry in Palghar district. The new centre aims to provide holistic…
Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv
Coherus BioSciences, Inc. (Coherus, NASDAQ: CHRS) today announced the launch of UDENYCA ONBODY™, the company’s on-body injector (OBI) presentation of UDENYCA® (pegfilgrastim-cbqv), is successfully underway, with a broad distribution of accounts nationwide ordering this innovative device, and patients now accessing its benefits….
Leading Pharma Adopts Veeva Vault Validation Management for Digital Validation Execution and Improved Efficiency
Veeva Systems (NYSE: VEEV) today announced that SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co. Ltd., a global biotech company, is using Veeva Vault Validation Management to streamline and accelerate their validation process. By adopting a validation solution with built-in best practices,…
RedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola
Investigational drugs opaganib and RHB-107 (upamostat) demonstrate distinct synergistic effect when combined individually with remdesivir, significantly improving potency while maintaining cell viability, in a new U.S. Army-funded and conducted in vitro Ebola virus study Opaganib and RHB-107 are both novel,…
New Drug Application of Mabwell’s 8MW0511 for Injection Accepted by NMPA
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that the new drug application of its recombinant (yeast-secreted) human serum albumin-human granulocyte colony-stimulating factor (I) fusion protein for injection (R&D code: 8MW0511) has been accepted by the National…
Medline recognizes SHARE Cancer Support as its first Pink Glove Grant recipient
Medline today announced SHARE Cancer Support as the recipient of its first-ever Pink Glove Grant. SHARE will receive a $25,000 grant from the Medline Foundation to help fund their program and expand breast cancer awareness within the Hispanic community. Across the nation, health outcomes…
17th edition of FICCI HEAL centred around ‘Healthcare METAmorphosis’ will be held on October 26-27 in New Delhi
India’s apex industry chamber, Federation of Indian Chambers of Commerce & Industry (FICCI) is all set to host the 17th edition of its annual healthcare conference– FICCI HEAL 2023 on October 26 and 27, 2023 at FICCI Federation House, New…
Dana-Farber Cancer Institute Makes no Substantial Movement Ahead of One-Day Strike by MNA Nurses at Merrimack Valley Clinic; DFCI Threatens to Lock Out Nurses Using Travelers
Dana-Farber Cancer Institute (DFCI) refused to make meaningful progress on key Merrimack Valley nurse issues during negotiations on September 19, and threatened to lock out nurses for two days following their planned one-day strike on September 27. DFCI told nurses…
Sunrise Oncology Centre expands its horizon with a comprehensive cancer care unit in Mumbai
After setting up consecutive successful cancer care centers across Mumbai & Goa, Sunrise Oncology Centre inaugurates its latest comprehensive cancer care centre on 17th August 2023 in Andheri West, Mumbai. Founded in 2017 by the visionary trio Dr. Ashay Karpe,…
Chemotherapy before surgery reduces risk of colon cancer recurrence, finds Cancer Research UK-funded trial
Administering chemotherapy before surgery can significantly reduce the risk of colon cancer recurrence, according to a Cancer Research UK-funded trial. The FOxTROT trial, led by the University of Birmingham and the University of Leeds, involved 1,053 colon cancer patients from…
